35th National Conference of the Italian Group for the Study of Neuromorphology, November 28-29, 2025
Vol. 69 No. s3 (2025): Proceedings of the 35th National Conference of the Italian Group for the Study of Neuromorphology

CONNECTOME-BASED BRAIN FINGERPRINTS PREDICT ART THERAPY RESPONSE IN PARKINSON’S DISEASE

Ielo A1,§, Genovese D2,3,§, Falcó-Roget J4, Amico E5,6, Norcini M7, Quartarone A1, Ghilardi MF8 and Cacciola A9,10 | 1IRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy; 2Institute of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 3Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy; 4Computational Neuroscience Group, Sano Centre for Computational Medicine, Kraków, Poland; 5School of Mathematics, University of Birmingham, Birmingham, UK; 6Centre for Human Brain Health, University of Birmingham, Birmingham, UK; 7NYU Langone Health, Department of Neurology, New York, USA; 8Department of Molecular, Cellular & Biomedical Sciences, School of Medicine, City University of New York, New York, USA; 9Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; 10IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. §Shared co-first authorship

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 12 December 2025
181
Views
0
Downloads

Authors

Art therapy has emerged as a promising non-pharmacological, complementary approach in Parkinson’s Disease (PD), engaging motor, cognitive, and emotional systems and promoting neuroplasticity. However, individual responses to art therapy are highly variable, and predictors of therapeutic efficacy remain largely unknown. Here, we propose a novel framework combining brain fingerprinting and machine learning to predict art therapy outcomes in PD. We mapped functional connectomes from restingstate functional MRI (fMRI) of PD patients before and after art therapy, assessed individual connectome-based fingerprints, and examined their spatial specificity. First, we found that functional connectomes derived from resting-state fMRI retained high levels of identifiability in both healthy controls and patients with PD, indicating that stable and subject-specific brain fingerprints are preserved even in the context of neurodegeneration. Second, we identified associations between fingerprint topography and cognitive domains relevant to PD. Although mean edge-wise reliability was comparable across conditions, the topography of reliability differed by group and session. In PD, reliable edges shifted toward posterior midline and occipital territories, with fewer stable connections in several associative systems. This pattern suggests a shift in reliability toward sensory-perceptual hubs and away from networks that support flexible control. Finally, leveraging network fingerprints, we computed subject-wise topology measures which served as input to a supervised classification framework designed to predict clinical responder versus non-responder status, based on changes in UPDRS-III scores. Among the tested classifiers, treebased methods provided the most robust predictive performance, with random forest achieving the highest performance, with an accuracy of 0.83 and a ROC-AUC of 0.80. Our results demonstrate that brain fingerprint-informed network measures capture interindividual variability in art therapy response, offering a datadriven, personalized approach to rehabilitation. This study provides the first evidence that functional connectome fingerprints can guide art therapy interventions, thus opening a new precision medicine framework in PD.

Downloads

Download data is not yet available.

Citations

No refs.

How to Cite



1.
CONNECTOME-BASED BRAIN FINGERPRINTS PREDICT ART THERAPY RESPONSE IN PARKINSON’S DISEASE: Ielo A1,§, Genovese D2,3,§, Falcó-Roget J4, Amico E5,6, Norcini M7, Quartarone A1, Ghilardi MF8 and Cacciola A9,10 | 1IRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy; 2Institute of Neurology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 3Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy; 4Computational Neuroscience Group, Sano Centre for Computational Medicine, Kraków, Poland; 5School of Mathematics, University of Birmingham, Birmingham, UK; 6Centre for Human Brain Health, University of Birmingham, Birmingham, UK; 7NYU Langone Health, Department of Neurology, New York, USA; 8Department of Molecular, Cellular & Biomedical Sciences, School of Medicine, City University of New York, New York, USA; 9Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; 10IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. §Shared co-first authorship. Eur J Histochem [Internet]. 2025 Dec. 12 [cited 2026 Jan. 19];69(s3). Available from: https://www.ejh.it/ejh/article/view/4464